Study Finds Deadly Risks in Sivibim
A recent study has shown that the antibiotic "Cefepime" is associated with an increased risk of death. The analysis was based on data from over 22,000 patients across 110 clinical trials. It was found that the mortality rate among those treated with Cefepime was 94.4% higher compared to those using other antibiotics, particularly among adults suffering from fever and low white blood cell counts. Although a correlation has been observed, the researchers emphasized that the results do not mean that Cefepime directly causes death. They recommended further studies to better understand the reasons behind this association, along with the necessity of adjusting the dosage to balance its effectiveness and safety.
Notice: This Is an AI-Generated Summary
Comments (0)